UK and Russia sign MoU on regulatory co-operation on medicines

Medicines regulators of the UK and Russian set out key principles to support their collaboration on improving public health.

This agreement will increase collaboration between the two bodies and further enhance co-operation in the field of regulation of medicines.

The MoU is designed to establish mechanisms of cooperation which will facilitate:

Dr Sam Atkinson, MHRA’s Director of the Inspection, Enforcement and Standards Division, said: "Working in an increasingly global environment, the sharing of intelligence between medicines regulators is the cornerstone of protecting the health system worldwide.

"Formalising our already close working relationships with international counterparts helps facilitate this exchange of information.

"This makes it easier for us to track down criminals, promote good practices internationally, and identify emerging safety trends to protect public health."